A lentiviral vector manufactured under GMP for a Phase I study in Acute Myeloid Leukaemia - manufacture summary, safety testing, application and post-administration safety-monitoring (2012)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 23
Parent Publication: HUMAN GENE THERAPY
Issue: 5
ISSN: 1043-0342